Contrary to what people would have us all believe, there is still no vaccine available for the coronavirus that has been approved by the U.S. Food and Drug Administration (FDA) for the “prevention of COVID-19 disease in persons 16 years of age and older,” Ethan Huff reports.
Pfizer’s “Comirnaty” injection was approved (more or less) in the fall, but it is not legally interchangeable with the Pfizer injections people received under the emergency authorization (EUA).
This distinction has led to much confusion about whether or not the injections can legally be given to the masses. It turns out that this is not the case, but it is being done anyway by devious means.
On August 23, the FDA supposedly granted full approval to Comirnaty, which was used by the Biden regime as leverage to force millions of people to take the injections. However, Comirnaty has not yet entered the market in the United States and there appear to be no plans to make it available there in the near future.
“As a reasonable explanation, Pfizer and its allies claimed at the outset that Comirnaty was not yet available because the EUA injections were still on the shelves and the FDA-approved version would soon become available to all,” Great Game India reports on the situation.
“It has been more than 4 months now, since the full approval, but Comirnaty is still not being distributed.”
A law passed under Reagan requires that experimental child-version vaccines get full approval before drug companies can obtain stronger regulatory immunity
It is important to emphasize that the FDA recognizes Comirnaty as a “legally distinct” product with “certain differences” compared to Pfizer-BioNTech’s EUA product.
At the same time, the FDA, which has financial ties to Pfizer, claims that the safety and effectiveness of both the EUA and approved injections are the same.
“‘Factcheckers’ are exploiting this last point of safety and efficacy to claim that people are still getting access to ingredients akin to the fully approved product,” Great Game India adds.
The U.S. Centers for Disease Control and Prevention (CDC) has also confirmed that Comirnaty “is not available for order at this time,” and that “Pfizer does not plan to produce any products with these National Drug Codes (NDCs) and labels in the coming months, while the EUA-approved product is still available and being made available for distribution in the U.S.”
Why, you may ask, is Pfizer refusing to make the fully authorized version available? The answer seems to be that Pfizer does not want to expose itself to legal liability issues.
While an EUA fully protects a drug manufacturer and provides no remedies to the patient, the law passed during the Reagan administration requires that a drug first obtain full approval for the pediatric version of the shot before more robust legal immunity can be granted for lawsuits related to injuries and deaths.
“The National Childhood Vaccine Injury Act (NCVIA), which became law in 1986, provides a legal liability shield to drug manufacturers if they obtain full approval for all ages,” the report explains.
“Is this now why Pfizer wants approval for children, so it can protect itself from lawsuits?”
Since these are pharmaceutical companies, this is almost guaranteed – because everyone knows that the drug industry cares about only one thing: profit. But is there any other reason why not only Pfizer, but also Moderna and Johnson & Johnson (J&J) “work relentlessly to get their products authorized for children, who are at almost no risk from COVID-19, but continue to have alarming side effects from the vaccine?”
The answer seems to be that these companies crave a comprehensive, additional layer of protection from lawsuits that can only be obtained if Comirnaty becomes available to all ages.